BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 11369066)

  • 1. Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study.
    Boström A; Lindman H; Swartling C; Berne B; Bergh J
    Radiother Oncol; 2001 Jun; 59(3):257-65. PubMed ID: 11369066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4.
    Miller RC; Schwartz DJ; Sloan JA; Griffin PC; Deming RL; Anders JC; Stoffel TJ; Haselow RE; Schaefer PL; Bearden JD; Atherton PJ; Loprinzi CL; Martenson JA
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1460-6. PubMed ID: 20800381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potent steroid cream is superior to emollients in reducing acute radiation dermatitis in breast cancer patients treated with adjuvant radiotherapy. A randomised study of betamethasone versus two moisturizing creams.
    Ulff E; Maroti M; Serup J; Falkmer U
    Radiother Oncol; 2013 Aug; 108(2):287-92. PubMed ID: 23827771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mometasone furoate cream reduces acute radiation dermatitis in patients receiving breast radiation therapy: results of a randomized trial.
    Hindley A; Zain Z; Wood L; Whitehead A; Sanneh A; Barber D; Hornsby R
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):748-55. PubMed ID: 25585779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing Dermolina-Henna Cream with Mometasone Cream in Improving Radiodermatitis Among Patients with Breast Cancer: A Randomized Active-Control Double-Blind Clinical Trial.
    Pasalar M; Ahadi B; Mirzaei HR; Buentzel J; Mehri Ardestani M; Kamian S; Heydarirad G
    J Integr Complement Med; 2022 Nov; 28(11):895-903. PubMed ID: 36103288
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of mometasone furoate 0.1% cream and hydrocortisone 1.0% cream in the treatment of childhood atopic dermatitis.
    Vernon HJ; Lane AT; Weston W
    J Am Acad Dermatol; 1991 Apr; 24(4):603-7. PubMed ID: 2033138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical corticosteroid therapy for acute radiation dermatitis: a prospective, randomized, double-blind study.
    Schmuth M; Wimmer MA; Hofer S; Sztankay A; Weinlich G; Linder DM; Elias PM; Fritsch PO; Fritsch E
    Br J Dermatol; 2002 Jun; 146(6):983-91. PubMed ID: 12072066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Randomized Trial of Mometasone Furoate 0.1% to Reduce High-Grade Acute Radiation Dermatitis in Breast Cancer Patients Receiving Postmastectomy Radiation.
    Ho AY; Olm-Shipman M; Zhang Z; Siu CT; Wilgucki M; Phung A; Arnold BB; Porinchak M; Lacouture M; McCormick B; Powell SN; Gelblum DY
    Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):325-333. PubMed ID: 29726361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients.
    Hanifin J; Gupta AK; Rajagopalan R
    Br J Dermatol; 2002 Sep; 147(3):528-37. PubMed ID: 12207596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proactive maintenance therapy with a topical corticosteroid for vulvar lichen sclerosus: preliminary results of a randomized study.
    Virgili A; Minghetti S; Borghi A; Corazza M
    Br J Dermatol; 2013 Jun; 168(6):1316-24. PubMed ID: 23398459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized, self-controlled, prospective assessment of the efficacy of mometasone furoate local application in reducing acute radiation dermatitis in patients with head and neck squamous cell carcinomas.
    Liao Y; Feng G; Dai T; Long F; Tang J; Pu Y; Zheng X; Cao S; Xu S; Du X
    Medicine (Baltimore); 2019 Dec; 98(52):e18230. PubMed ID: 31876704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical use of recombinant human epidermal growth factor (EGF)-based cream to prevent radiation dermatitis in breast cancer patients: a single-blind randomized preliminary study.
    Kong M; Hong SE
    Asian Pac J Cancer Prev; 2013; 14(8):4859-64. PubMed ID: 24083759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term, intermittent treatment of chronic hand eczema with mometasone furoate.
    Veien NK; Olholm Larsen P; Thestrup-Pedersen K; Schou G
    Br J Dermatol; 1999 May; 140(5):882-6. PubMed ID: 10354026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant role of a new emollient cream in patients with palmar and/or plantar psoriasis: a pilot randomized open-label study.
    Cassano N; Mantegazza R; Battaglini S; Apruzzi D; Loconsole F; Vena GA
    G Ital Dermatol Venereol; 2010 Dec; 145(6):789-92. PubMed ID: 21139557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open study of efficacy and safety of long-term treatment with mometasone furoate fatty cream in the treatment of adult patients with atopic dermatitis.
    Faergemann J; Christensen O; Sjövall P; Johnsson A; Hersle K; Nordin P; Edmar B; Svensson A
    J Eur Acad Dermatol Venereol; 2000 Sep; 14(5):393-6. PubMed ID: 11305382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, Prospective, Open-label Phase III Trial Comparing Mebo Ointment With Biafine Cream for the Management of Acute Dermatitis During Radiotherapy for Breast Cancer.
    Geara FB; Eid T; Zouain N; Thebian R; Andraos T; Chehab C; Ramia P; Youssef B; Zeidan YH
    Am J Clin Oncol; 2018 Dec; 41(12):1257-1262. PubMed ID: 29889137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic treatment with a potent corticosteroid cream ameliorates radiodermatitis, independent of radiation schedule: A randomized double blinded study.
    Ulff E; Maroti M; Serup J; Nilsson M; Falkmer U
    Radiother Oncol; 2017 Jan; 122(1):50-53. PubMed ID: 27913066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mometasone furoate 0.1%-salicylic acid 5% ointment versus mometasone furoate 0.1% ointment in the treatment of moderate-to-severe psoriasis: a multicenter study.
    Koo J; Cuffie CA; Tanner DJ; Bressinck R; Cornell RC; DeVillez RL; Edwards L; Breneman DL; Piacquadio DJ; Guzzo CA; Monroe EW
    Clin Ther; 1998; 20(2):283-91. PubMed ID: 9589819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of once-daily application of mometasone furoate 0.1% cream compared with twice-daily hydrocortisone valerate 0.2% cream in pediatric atopic dermatitis patients who failed to respond to hydrocortisone: mometasone furoate study group.
    Lebwohl M
    Int J Dermatol; 1999 Aug; 38(8):604-6. PubMed ID: 10487451
    [No Abstract]   [Full Text] [Related]  

  • 20. Induction of p53 expression in skin by radiotherapy and UV radiation: a randomized study.
    Ponten F; Lindman H; Bostrom A; Berne B; Bergh J
    J Natl Cancer Inst; 2001 Jan; 93(2):128-33. PubMed ID: 11208882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.